ABBOTT LABORATORIES (ABT) › Capital ExpendituresABBOTT LABORATORIES (ABT) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2007: $1.66B2008: $1.29B2009: $1.09B2010: $1.02B2011: $1.49B2012: $1.79B2013: $1.15B2014: $1.08B2015: $1.11B2016: $1.12B2017: $1.14B2018: $1.39B2019: $1.64B2020: $2.18B2021: $1.89B2022: $1.78B2023: $2.20B2024: $2.21B2025: $2.17B$2.17B2007Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$2.17B-1.6%2024$2.21B+0.2%2023$2.20B+23.9%2022$1.78B-5.7%2021$1.89B-13.4%2020$2.18B+32.9%2019$1.64B+17.5%2018$1.39B+22.8%2017$1.14B+1.2%2016$1.12B+1.0%2015$1.11B+3.1%2014$1.08B-5.9%2013$1.15B-36.2%2012$1.79B+20.4%2011$1.49B+46.9%2010$1.02B-6.8%2009$1.09B-15.4%2008$1.29B-22.2%2007$1.66B—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share